Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures

October 2012

Please see the October 2013 FDA Drug Safety Communication regarding Potiga and skin discoloration/retinal abnormalities

You'll see patients on Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures.

It has a unique mechanism...and some unusual side effects.

In fact, FDA will require a REMS risk management program to alert patients and prescribers to the risk of urinary retention.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote